Stock Events

Consun Pharmaceutical Limited 

$0.58
18
+$0+0% Monday 13:04

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
0
Dividend Yield
9.92%
Dividend
0.06

Upcoming

Dividends

9.92%Dividend Yield
10Y Growth
N/A
5Y Growth
8.51%
3Y Growth
14.21%
1Y Growth
0.23%

Earnings

22AugConfirmed
Q1 2017
Q2 2017
Q1 2018
Q2 2021
Q1 2023
Q4 2023
Next
0
0.08
0.17
0.25
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CPHGF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Sanofi
SNY
Mkt Cap130B
Sanofi operates in the pharmaceutical sector, offering a wide range of medicines and vaccines, directly competing with Consun Pharmaceutical's product offerings.
Pfizer
PFE
Mkt Cap163.88B
Pfizer is a global biopharmaceutical company that develops and manufactures drugs and vaccines, including in areas where Consun Pharmaceutical is active.
Novartis
NVS
Mkt Cap244.62B
Novartis is a multinational pharmaceutical company that produces drugs in many of the same therapeutic areas as Consun Pharmaceutical, making it a direct competitor.
Merck &
MRK
Mkt Cap323.59B
Merck & Co., Inc. is a leading global biopharmaceutical company that competes with Consun Pharmaceutical in developing medicines for various diseases.
GSK
GSK
Mkt Cap81.16B
GlaxoSmithKline is a global healthcare company that researches and develops a broad range of pharmaceutical products, competing with Consun Pharmaceutical in multiple areas.
Abbvie
ABBV
Mkt Cap300.69B
AbbVie is a biopharmaceutical company that has a competitive portfolio of drugs, directly competing with Consun Pharmaceutical in several therapeutic areas.
Johnson & Johnson
JNJ
Mkt Cap360.71B
Johnson & Johnson is a diversified healthcare giant that manufactures pharmaceuticals across a broad range of areas, competing with Consun Pharmaceutical.
Bristol-Myers Squibb
BMY
Mkt Cap82.02B
Bristol Myers Squibb is a global biopharmaceutical company with a focus on discovering, developing, and delivering innovative medicines that compete with Consun Pharmaceutical.
Astrazeneca
AZN
Mkt Cap245.69B
AstraZeneca is a global, science-led biopharmaceutical business that competes in developing and commercializing prescription medicines in areas overlapping with Consun Pharmaceutical.
Roche
RHHBY
Mkt Cap200.6B
Roche Holding AG is a leader in research-focused healthcare with strengths in pharmaceuticals and diagnostics, competing in areas relevant to Consun Pharmaceutical's interests.

About

Consun Pharmaceutical Group Limited, an investment holding company, researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People's Republic of China. The company operates through two segments, Consun Pharmaceutical and Yulin Pharmaceutical. It offers uremic clearance granule to treat chronic kidney diseases; Yishen Huashi particles to treat proteinuria; Gadopentetate Dimeglumine injections for magnetic resonance image diagnostics of nervous centralis, stomach, chest, pelvic cavity, and extremities, as well as for renal function assessment; and Iopamidol injections used for neuroradiology, angiography, and urography. The company also provides Yuanli Kang, an iron-dextrin oral solution; Yibao Yua, an erythromycin estolate suspension; Yuantong Ning, a cetirizine hydrochloride oral solution; and Zhixueling capsules to treat hysteromyoma bleeding, prolonged lochiorrhea, intermenstrual bleeding, bleeding after use of a contraceptive ring, hemorrhoidal bleeding, and epistaxis. In addition, it offers Gyn Antidysmenorrheic tablets for the treatment of irregular menstruation, irregular period during perimenopause, and abdominal pain during menstruation due to hepatic depression and blood deficiency; and Antibacterial Fujie lotion for staphylococcus aureus, Candida albicans, and escherichia coli in the feminine vaginal. Further, the company provides bone-setting liquid; Yunxiang analgesic tincture for treatment of rheumatism, common cold, headache, stomachache, cardiodynia, and pain in gastral cavity and chilblain; Sanqi Chuangchun capsules for activating blood circulation and dispersing blood stasis; and Shiduqing capsules and tablets, and Paeonol ointment for skin disease. Additionally, it offers hepatobiliary, gastroenterology, tonics, and other medicines. The company was founded in 1997 and is headquartered in Guangzhou, the People's Republic of China.
Show more...
CEO
Mr. Meng An
Employees
3009
Country
Hong Kong
ISIN
KYG2524A1031
WKN
000A1XAEC

Listings